BMC Structural Biology BioMed Central

BackgroundHuman serum albumin (HSA) is an abundant plasma protein that binds a wide variety of hydrophobic ligands including fatty acids, bilirubin, thyroxine and hemin. Although HSA-heme complexes do not bind oxygen reversibly, it may be possible to develop modified HSA proteins or heme groups that will confer this ability on the complex.ResultsWe present here the crystal structure of a ternary HSA-hemin-myristate complex, formed at a 1:1:4 molar ratio, that contains a single hemin group bound to subdomain IB and myristate bound at six sites. The complex displays a conformation that is intermediate between defatted HSA and HSA-fatty acid complexes; this is likely to be due to low myristate occupancy in the fatty acid binding sites that drive the conformational change. The hemin group is bound within a narrow D-shaped hydrophobic cavity which usually accommodates fatty acid; the hemin propionate groups are coordinated by a triad of basic residues at the pocket entrance. The iron atom in the centre of the hemin is coordinated by Tyr161.ConclusionThe structure of the HSA-hemin-myristate complex (PDB ID 1o9x) reveals the key polar and hydrophobic interactions that determine the hemin-binding specificity of HSA. The details of the hemin-binding environment of HSA provide a structural foundation for efforts to modify the protein and/or the heme molecule in order to engineer complexes that have favourable oxygen-binding properties.

[1]  S. Curry,et al.  Binding of the General Anesthetics Propofol and Halothane to Human Serum Albumin , 2000, The Journal of Biological Chemistry.

[2]  Edward N. Baker,et al.  Crystal structure of hemopexin reveals a novel high-affinity heme site formed between two β-propeller domains , 1999, Nature Structural Biology.

[3]  Chung-Eun Ha,et al.  Structural basis of albumin–thyroxine interactions and familial dysalbuminemic hyperthyroxinemia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Hamilton,et al.  Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. C. Carter,et al.  Atomic structure and chemistry of human serum albumin , 1993, Nature.

[6]  F. Altruda,et al.  Hemopexin: structure, function, and regulation. , 2002, DNA and cell biology.

[7]  P. Brick,et al.  Crystal structure of human serum albumin complexed with fatty acid reveals an asymmetric distribution of binding sites , 1998, Nature Structural Biology.

[8]  G. Sudlow,et al.  The characterization of two specific drug binding sites on human serum albumin. , 1975, Molecular pharmacology.

[9]  D. Carter,et al.  Preliminary crystallographic studies of four crystal forms of serum albumin. , 1994, European journal of biochemistry.

[10]  P. Brick,et al.  Fatty acid binding to human serum albumin: new insights from crystallographic studies. , 1999, Biochimica et biophysica acta.

[11]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[12]  S. Curry,et al.  Crystal Structure Analysis of Warfarin Binding to Human Serum Albumin , 2001, The Journal of Biological Chemistry.

[13]  D. Carter,et al.  The atomic structure of human methemalbumin at 1.9 A. , 2002, Biochemical and biophysical research communications.

[14]  F. Rüker,et al.  The Three Recombinant Domains of Human Serum Albumin , 1999, The Journal of Biological Chemistry.

[15]  S. Curry,et al.  Crystallographic analysis reveals common modes of binding of medium and long-chain fatty acids to human serum albumin. , 2000, Journal of molecular biology.

[16]  E. Tsuchida,et al.  Exchange transfusion with albumin-heme as an artificial O2-infusion into anesthetized rats: physiological responses, O2-delivery, and reduction of the oxidized hemin sites by red blood cells. , 2000, Bioconjugate chemistry.

[17]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[18]  P. Kraulis A program to produce both detailed and schematic plots of protein structures , 1991 .

[19]  S. Takeoka,et al.  Human serum albumin-bound synthetic hemes as an oxygen carrier: determination of equilibrium constants for heme binding to host albumin. , 1998, Artificial cells, blood substitutes, and immobilization biotechnology.

[20]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[21]  S. Curry,et al.  Crystal structures of human serum albumin complexed with monounsaturated and polyunsaturated fatty acids. , 2001, Journal of molecular biology.

[22]  S. Takeoka,et al.  Properties of and oxygen binding by albumin-tetraphenylporphyrinatoiron(II) derivative complexes. , 1997, Bioconjugate chemistry.

[23]  T. Peters,et al.  All About Albumin: Biochemistry, Genetics, and Medical Applications , 1995 .

[24]  R M Esnouf,et al.  An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. , 1997, Journal of molecular graphics & modelling.

[25]  E. Tsuchida,et al.  Human serum albumin incorporating Tetrakis(o-pivalamido) phenylporphinatoiron(II) derivative as a totally synthetic O2-carrying hemoprotein. , 1999, Bioconjugate chemistry.

[26]  J Navaza,et al.  Implementation of molecular replacement in AMoRe. , 2001, Acta crystallographica. Section D, Biological crystallography.

[27]  Q. Gibson,et al.  Flash photolysis of the serum albumin-heme-CO complex. , 1989, Biochemistry.

[28]  P. Adams,et al.  Kinetics and mechanism of the interaction between human serum albumin and monomeric haemin. , 1980, The Biochemical journal.

[29]  E. Tsuchida,et al.  Effect of heme structure on O(2)-binding properties of human serum albumin-heme hybrids: intramolecular histidine coordination provides a stable O(2)-adduct complex. , 2002, Bioconjugate chemistry.

[30]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[31]  K. Kobayashi,et al.  Crystal structure of human serum albumin at 2.5 A resolution. , 1999, Protein engineering.

[32]  J. Eaton,et al.  Pro-oxidant and cytotoxic effects of circulating heme. , 2002, Blood.

[33]  W. Delano The PyMOL Molecular Graphics System , 2002 .

[34]  M. Suematsu,et al.  Human serum albumin incorporating synthetic heme: red blood cell substitute without hypertension by nitric oxide scavenging. , 2003, Journal of biomedical materials research. Part A.

[35]  T. Komatsu,et al.  Kinetics of CO and O(2) binding to human serum albumin-heme hybrid. , 2000, Bioconjugate chemistry.